logo
Select company
Select metric
57.12%Cash to Assets Ratio
VS
Market
93
Sector
77
Industry
67
History
80
$ 1.83Close
$ 0.51 - $ 4.12 52-Week Range
Ticker Information

Ticker

MTNB

Company Name

MATINAS BIOPHARMA HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

MATINAS BIOPHARMA HOLDINGS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MTNB - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 11.42M$ 6.53M57.12%
3/31/2025$ 12.04M$ 6.92M57.53%
12/31/2024$ 12.64M$ 7.28M57.62%
9/30/2024$ 20.58M$ 10.29M50.03%
6/30/2024$ 24.36M$ 4.22M17.3%
3/31/2024$ 19.61M$ 1.07M5.46%
12/31/2023$ 25.1M$ 4.79M19.07%
9/30/2023$ 29.79M$ 6.41M21.51%
6/30/2023$ 34.02M$ 9.74M28.63%
3/31/2023$ 38.26M$ 5.74M15%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for MATINAS BIOPHARMA HOLDINGS INC is calculated as follows: CashnEq [ $ 7.24M ] / Assets [ $ 74.81M ]
(=) Cash to Assets [ 9.67% ]

MTNB - Cash to Assets Ratio, Last 5 years

5.46%

Minimum

Mar 31, 2024

57.62%

Maximum

Dec 31, 2024

29.86%

Average

26.07%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.76% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.71%
average9.76%
median6.41%
std9.51%